Inventiva S.A. current report, Q1 FY2023

Inventiva S.A. — Form 6-K Summary

Reporting date: March 29, 2023. The filing is a Form 6-K submitted by Inventiva S.A., a French foreign private issuer, under Exchange Act Rules 13a-16 or 15d-16. The filing transmits a press release dated March 29, 2023 as Exhibit 99.1.

Financial and Operating Information

The provided filing text does not include the contents of the referenced press release and therefore does not provide clear values for revenue, profit or loss, cash flow, margins, debt, cash, liquidity, operating results, or other financial metrics.

Changes Versus Prior Period

The filing text does not provide information permitting comparison with a prior comparable period.

Guidance, Outlook, Risks, and Unusual Items

The filing text does not provide the referenced press release or any clear guidance, outlook, management commentary, risk disclosures, contingencies, or unusual items.

Key Facts to Verify

  • Obtain and review Exhibit 99.1, the press release dated March 29, 2023.
  • Verify whether the press release contains financial results, clinical or business updates, financing information, or forward-looking statements.
  • Confirm any disclosed liquidity, funding, debt, milestone, or regulatory developments in the complete exhibit.